INNOVATIVE EXTRACORPOREAL TECHNOLOGIES

Download full text PDF
Issue: 
12
Year: 
2017

Professor A. Sokolov, MD I.I. Mechnikov North-Western State Medical University, Saint Petersburg

The paper presents the classification of extracorporeal techniques according to their level of selectivity. Current selective and specific extracorporeal technologies are characterized; their advantages and disadvantages are described. Selective and specific extracorporeal technologies can be designed if it is precisely known that target-removed molecules or blood cells play a key role in the pathogenesis of the disease. Their introduction is reasonable if it leads to the increased efficiency and safety of extracorporeal treatment.
Keywords: 
extracorporeal blood correction
immunosorption
plasmapheresis
selectivity

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Sokolov A.A. Sovremennye ekstrakorporal'nye tehnologii: kaskadnaja plazmofil'tratsija / SPb, 2013; 60 s.
  2. van Buuren F., Kreickmann S., Horstkotte D. et al. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures // Clin. Res. Cardiol. Suppl. – 2012; 7: 24–30.
  3. Hirata N., Kuriyama T., Yamawaki N. Immusorba TR and PH // Ther. Apher. Dial. – 2003; 7 (1): 85–90.
  4. Wu F., Heng K., Salleh R. et al. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+, and Baxter Amicus // Transfus. Apher. Sci. – 2012; 47 (3): 345–50.
  5. Cancelas J., Padmanabhan A., Le T. et al. Spectra Optia granulocyte apheresis collections result in higher collection efficiency of viable, functional neutrophils in a randomized, crossover, multicenter trial // Transfusion. – 2015; 55 (4): 748–55.
  6. Leitner G., Worel N., Vogelsang H. Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease // Transfus. Med. Hemother. – 2012; 39 (4): 246–52.
  7. Afanas'eva O.I., Altynova E.V., Sokolov A.A. i dr. Sravnitel'nyj analiz effektivnosti i spetsifichnosti raznyh sorbentov dlja afereza lipoproteidov nizkoj plotnosti // Bjull. eksperiment. biol. i meditsiny. – 2006; 142 (11): 532–7.
  8. Rönspeck W., Brinckmann R., Egner R. et al. Peptide based adsorbers for therapeutic immunoadsorption // Ther. Apher. Dial. – 2003; 7 (1): 91–7.
  9. Mock U., Nickolay L., Philip B. et al. Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy // Cytotherapy. – 2016; 18 (8): 1002–11.
  10. Poullin P., Announ N., Mugnier B. et al. Protein A-immunoadsorption (Prosorba column) in the treatment of rheumatoid arthritis // Joint Bone Spine. – 2005; 72 (2): 101–3.
  11. Manuilov A.S., Bardakov S.N., Sokolov A.A. i dr. Sravnitel'naja otsenka dinamiki kontsentratsii immunoglobulinov pri kaskadnoj plazmofil'tratsii i immunosorbtsii s regeneratsiej sorbtsionnyh kolonok. Lechebnyj gemaferez i ekstrakorporal'naja gemokorrektsija: dostizhenija i nadezhdy. – Tezisy dokl. III Konf. natsional'n. obsch. spets. v obl. gemafereza i ekstrakorp. gemokor. SPb, 2017; s. 60–1.